Table 1.
Patient and Clinical Characteristics Stratified by Receipt of Perioperative Venous Thromboembolism Pharmacologic Prophylaxis
| No perioperative VTE pharmacologic prophylaxis (n=1,826) |
Perioperative VTE pharmacologic prophylaxis (n=2,369) |
p Value | |
|---|---|---|---|
| Age, y, mean ± SD |
61.4 ± 15.7 | 60.9 ± 15.4 | 0.33 |
| Female sex, n (%) | 991 (54.3) | 1,277 (53.9) | 0.81 |
| Smoker, n (%) | 285 (15.8) | 391 (16.7) | 0.47 |
| BMI, n (%) <20 20-25 25-30 >30 |
147 (8.8) 506 (30.1) 590 (35.1) 437 (26.0) |
173 (7.8) 660 (29.8) 729 (32.9) 651 (29.4) |
0.1 |
| Hypertension, n (%) |
787 (43.2) | 1,033 (43.6) | 0.78 |
| Coronary artery disease, n (%) |
211 (11.6) | 258 (10.9) | 0.47 |
| Previous history of DVT/PE, n (%) |
52 (2.9%) | 96 (4.1%) | 0.04 |
| Length of stay, d, mean ± SD |
7.6 ± 6.8 | 7.8 ± 9.8 | 0.66 |
| OR time, min, mean ± SD |
156.0 ± 95.8 | 155.5 ± 92.1 | 0.85 |
| Charlson comorbididty index, n (%) 0 1 2 3+ Mean± SD |
733 (40.1) 163 (8.9) 381 (20.9) 549 (30.1) 0.33±0.65 |
977 (41.2) 225 (9.5) 548 (23.1) 619 (26.1) 0.40±0.70 |
0.07 |
| Indication for procedure, n (%) Malignancy IBD |
716 (39.2) 140 (7.7) |
916 (38.7) 208 (8.9) |
0.72 0.20 |
| Application of pneumatic compressions, n (%) |
1,641 (91.0) | 2,223 (94.4) | <0.001 |
VTE, venous thromboembolism.